Use of CMFDA and CMTMR Fluorescent Dyes in FACS®-Based Antibody Screening

Cell-based immunizations are often used when membrane antigens are difficult to purify. To confirm that an antibody binding to the surface of a cell line is, in fact, binding to the desired antigen, FACS® can be performed independently on two cell lines, a transfected cell line expressing the antige...

Full description

Saved in:
Bibliographic Details
Main Authors: X.-P. Yang, M. Gallo, I. Ngan, M. Nocerini, M.M. Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2002-03-01
Series:BioTechniques
Online Access:https://www.future-science.com/doi/10.2144/02323dd05
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell-based immunizations are often used when membrane antigens are difficult to purify. To confirm that an antibody binding to the surface of a cell line is, in fact, binding to the desired antigen, FACS® can be performed independently on two cell lines, a transfected cell line expressing the antigen of interest and a control cell line not expressing the antigen. Antibodies binding only to the transfected cell line are then selected for further analysis. This approach can be challenging if a large number of antibodies need to be screened and the antibody quantities are limited. Here we describe a novel method that combines the above two steps of FACS screening into a single step, based on the use of two fluorochromes, CMFDA and CMTMR, to stain transfected and control cell lines, respectively. Antibodies conjugated to a third fluorochrome are then added to the combined cells, followed by three-color FACS analysis. The newly modified FACS method is simple, sensitive, and high throughput. It can be used for antibody screening in multiple cell lines simultaneously.
ISSN:0736-6205
1940-9818